en
svPress releases
Press release 2020-03-23
Xspray Pharma publishes prospectus in connection with its listing on Nasdaq Stockholm
Regulatory press release 2020-03-18
Xspray Pharma approved for listing on Nasdaq Stockholm
Regulatory press release 2020-03-17
Xspray receives notification of manufacturing approval and provides update on clinical studies
Press release 2020-02-28
Xspray Pharma publishes Interim report Q4, January – December 2019
Press release 2020-02-24
Notice of extraordinary general meeting of Xspray Pharma AB (publ)
Press release 2020-02-18
Three additional product patents in the US for HyNap-Dasa
Press release 2020-02-12
Additional product patent in the US for HyNap-Dasa
Regulatory press release 2020-02-11
Stability studies initiated with Xspray’s HyNap-Dasa tablets
Press release 2019-12-19
First batch of HyNap-Dasa tablets manufactured on commercial scale according to GMP
Regulatory press release 2019-12-05